Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 135-146

  Aharoni, Rina ^a   Teitelbaum, Dvora ^a   Sela, Michael ^a   Arnon, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Bystander suppression; Copaxone ; Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis (MS); Regulatory T cells; Th2 cytokines

Indexed keywords

COPOLYMER; CYTOKINE; GLATIRAMER; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CROSS REACTION; EFFECTOR CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CLONE CELLS; CROSS REACTIONS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; PEPTIDE FRAGMENTS; PEPTIDES; TH2 CELLS;

EID: 0032476565     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00166-0     Document Type: Article

References (49)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
2. Adorini L., Sinigaglia F. Pathogenesis and immunotherapy of autoimmune diseases. Immunol. Today. 18:1997;209-211.
3. Aharoni A., Teitelbaum D., Arnon R. T suppressor hybridomas and interleukin-2-dependent lines induced by copolymer 1 or by spinal cord homogenate down-regulate experimental allergic encephalomyelitis. Eur. J. Immunol. 23:1993;17-25.
4. Aharoni R., Teitelbaum D., Sela M., Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10821-10826.
5. Allen J.E., Maizels R.M. Th1-Th2: reliable paradigm or dangerous dogma? Immunol. Today. 18:1997;387-392.
6. Al-Sabbagh A., Miller A., Santos L.M.B., Weiner H.L. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL/J mouse. Eur. J. Immunol. 24:1994;2104-2109.
7. Ben-Nun A., Lando Z. Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. J. Immunol. 130:1983;1205-1209.
8. Ben-Nun A., Mendel I., Bakimer R., Fridkis-Hareli M., Teitelbaum D., Arnon R., Sela M. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer-1 on Mog induced disease. J. Neurol. 243:1996;S14-S22.
9. Bernard C.C.A., Kerlero de Rosbo N. Multiple sclerosis: an autoimmune disease of multifunctional etiology. Curr. Opin. Immunol. 4:1992;760-765.
10. Brennan F.M., Feldmann M. Cytokines in autoimmunity. Curr. Opin. Immunol. 8:1996;872-877.
11. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
12. Fridkis-Hareli M., Teitelbaum D., Gurevich E., Pecht I., Brautbar C., Kwon O.J., Brenner T., Arnon R., Sela M. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells - specificity and promiscuity. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4872-4876.
13. Hirshfeld H., Teitelbaum D., Arnon R., Sela M. Basic encephalitogenic protein: a simplified purification on sulfoethyl Sephadex. FEBS Lett. 7:1970;317-320.
14. Johnson, K.P., Brooks, B.R., Cohen, J.A., Ford, C.C., Goldstein, J., Lisak, R.P., Myers, L.W., Panitch, H.S., Rose, J.W., Sciffer, R.B., Vollmer, T., Weiner, L.P., Wolinski, J.S., The Copolymer 1 Multiple Sclerosis Study Group, 1995. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology, 1, 65-70.
15. Johnson, K.P., Brooks, B.R., Cohen, J.A., Ford, C.C., Goldstein, J., Lisak, R.P., Myers, L.W., Panitch, H.S., Rose, J.W., Sciffer, R.B., Vollmer, T., Weiner, L.P., Wolinski, J.S., the Copolymer 1 Multiple Sclerosis Study Group, 1998. Extended use of Glatiramer Acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology, 50, 701-708.
16. Keith A.B., Arnon R., Teitelbaum D., Caspary E.A., Wisniewski M.M. The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental autoimmune encephalomyelitis in guinea pigs. J. Neurol. Sci. 42:1979;267-274.
17. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlated with recovery. J. Immunol. 149:1992;2496-2505.
18. Kerlero de Rosbo N., Milo R., Lees M.B., Burger D., Bernard C.C.A., Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. J. Clin. Invest. 92:1993;2602-2608.
19. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1992;1355-1364.
20. Krakowski M.L., Owens T. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2840-2847.
21. Lafaille J., Van de Keere F., Hsu A.L., Baron J.B., Hass W., Raine C.S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient host rather than protect them from the disease. J. Exp. Med. 186:1997;307-312.
22. Lando Z., Teitelbaum D., Arnon R. Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE. J. Immunol. 123:1979;2156-2160.
23. Lees M.B., Kuchroo V.K., Sobel R.A. Myelin proteolipid protein: its role in experimental allergic encephalomyelitis (EAE). Int. Pediatr. 6:1991;84-90.
24. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
25. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:1995;75-85.
26. b mice:fine specificity and T cell receptor VB expression of encephalitogenic T cells. Eur. J. Immunol. 25:1995;1951-1959.
27. Merrifield R.B. Automated synthesis of peptides. Science. 150:1965;178-185.
28. Merrill J.E., Kono D.H., Clayton J., Ando D.G., Hinton D.R., Hofman F.M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. U.S.A. 89:1992;574-578.
29. Miller S.D., Karpus W.J. The immunopathogenesis and regulation of T cell-mediated demyelinating diseases. Immunol. Today. 15:1994;356-361.
30. Miller A., Lider O., Roberts A.B., Sporn M.B., Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. U.S.A. 89:1992;421-425.
31. Miller A., Shapiro S., Kinarti A., Hongman S., Rawashdeh H., Dishon S., Lahat N. Treatment of multiple sclerosis with copolymer 1: implicating mechanism of Th1 to Th2/Th3 immune deviation and bystander suppression. Multiple Sclerosis: Clinical and Laboratory Research. 3:1997;278.
32. Mosmann T.R., Coffmann R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
33. Mosmann R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-145.
34. Nicholson L.B., Kuchroo V.K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8:1996;837-842.
35. Nicholson L.B., Murtaza A., Hafler B.P., Sette A., Kuchroo V.K. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9279-9284.
36. Pakala S.V., Kurrer M.O., Katz J.C. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:1997;299-306.
37. Rocken M., Racke M., Shevach E.M. IL-4 induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today. 17:1996;225-231.
38. Teitelbaum D., Meshorer A., Hirshfeld T., Arnon R., Sela M. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur. J. Immunol. 1:1971;242-248.
39. Teitelbaum D., Webb C., Meshorer A., Arnon R., Sela M. Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen. Eur. J. Immunol. 3:1973;273-279.
40. Teitelbaum D., Webb C., Bree M., Meshorer A., Arnon R., Sela M. Suppression of experimental allergic encephalomyelitis induced in rhesus monkeys by a synthetic basic copolymer. Clin. Immunol. Immunopathol. 3:1974;256-262.
41. Teitelbaum D., Aharoni R., Sela M., Arnon R. Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9528-9532.
42. Teitelbaum D., Fridkis-Hareli M., Arnon R., Sela M. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses. J. Neuroimmunol. 64:1996;209-217.
43. Teitelbaum D., Arnon R., Sela M. Copolymer 1: from basic research to clinical application. Cell. Mol. Life Sci. 53:1997;24-28.
44. Van der Veen R.C., Stohlman S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of IL-4 and IL-10. J. Neuroimmunol. 48:1993;213-220.
45. Van Noort J.M., Van Sechel A.C., Bajramovic J.J., Ouagmiri M.E., Polman C.H., Lassmann H., Ravid R. The small heat-shock protein B-crystallin as candidate autoantigen in multiple sclerosis. Nature. 375:1995;798-801.
46. Webb C., Teitelbaum D., Arnon R., Sela M. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis. Eur. J. Immunol. 3:1973;279-286.
47. Webb C., Teitelbaum D., Herz A., Arnon R., Sela M. Molecular requirements involved in suppression of EAE by synthetic basic copolymers of amino acids. Immunochemistry. 13:1976;333-337.
48. Wekerle H., Linington C., Lassmann H., Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 9:1986;271-277.
49. Winer, B.J., 1971. Combining several independent tests on the same hypothesis in statistical principles. In: Principles in Experimental Design. McGraw-Hill, New York, pp. 49-50.